BIONOR LABORATORIES AS

3732 SKIEN

Finances

Share Ownership

Return on Equity

11,83 %

Current Ratio

3,64

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 631 000	1 915 000	1 720 000	1 737 000
Net Income	189 000	320 000	226 000	204 000
Total Assets	1 958 000	2 150 000	1 928 000	1 819 000
Total Equity	1 598 000	1 560 000	1 440 000	1 364 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 631 000	1 915 000	1 720 000	1 737 000
Expenditure	1 407 000	1 521 000	1 485 000	1 446 000
Operating Profit	223 000	393 000	235 000	292 000
Financial Income	44 000	23 000	87 000	7 000
Financial Costs	25 000	37 000	32 000	37 000
Financial Balance	19 000	−14 000	55 000	−30 000
Earnings Before Tax	242 000	379 000	289 000	262 000
Tax	53 000	60 000	64 000	58 000
Net Income	189 000	320 000	226 000	204 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	653 000	184 000	230 000	276 000
Total Current Assets	1 305 000	1 966 000	1 698 000	1 543 000
Total Assets	1 958 000	2 150 000	1 928 000	1 819 000
Total Retained Equity	1 498 000	1 460 000	1 340 000	1 264 000
Total Equity	1 598 000	1 560 000	1 440 000	1 364 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	359 000	590 000	488 000	455 000
Total Equity and Debt	1 958 000	2 150 000	1 928 000	1 819 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 631 000	1 915 000	1 720 000	1 737 000
Other Income	0	0	0	0
Revenue	1 631 000	1 915 000	1 720 000	1 737 000
Cost of Goods Sold	444 000	520 000	480 000	396 000
Salary Costs	220 000	568 000	539 000	507 000
Depreciation	46 000	46 000	46 000	46 000
Impairment	0	0	0	0
Expenditure	1 407 000	1 521 000	1 485 000	1 446 000
Operating Profit	223 000	393 000	235 000	292 000
Financial Income	44 000	23 000	87 000	7 000
Financial Costs	25 000	37 000	32 000	37 000
Financial Balance	19 000	−14 000	55 000	−30 000
Dividends	150 000	200 000	150 000	150 000
Net Income	189 000	320 000	226 000	204 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	138 000	184 000	230 000	276 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	515 000	0	0	0
Total Fixed Assets	653 000	184 000	230 000	276 000
Stock	57 000	57 000	159 000	147 000
Total Investments	0	0	0	0
Cash, Bank	1 082 000	1 677 000	1 459 000	1 289 000
Total Current Assets	1 305 000	1 966 000	1 698 000	1 543 000
Total Assets	1 958 000	2 150 000	1 928 000	1 819 000
Total Equity	1 598 000	1 560 000	1 440 000	1 364 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	94 000	72 000	73 000	97 000
Unpaid Taxes	35 000	76 000	81 000	37 000
Dividends	150 000	200 000	150 000	150 000
Other Current Debt	27 000	148 000	120 000	113 000
Total Current Debt	359 000	590 000	488 000	455 000
Total Equity and Debt	1 958 000	2 150 000	1 928 000	1 819 000

Financial indicators	2022	2021	2020	2019
Return on Equity	11,83 %	20,51 %	15,69 %	14,96 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	13,67 %	20,52 %	13,66 %	16,81 %
Current Ratio	3,64	3,33	3,48	3,39
Quick Ratio	4,32	3,69	5,16	5,01
Equity Ratio	0,82	0,73	0,75	0,75
Gross Profit Margin	72,78 %	72,85 %	72,09 %	77,2 %